Skip to main content

Table 1 Patients demographics

From: Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients

  100 μg 200 μg
No. patients enrolled 13 12
Sex
  Male 13 11
  Female 0 1
Age
  Median 69 64.5
  Range 49-72 53-79
Prior therapy
  Surgery 6 5
  Radiotherapy 11 7
  Chemotherapy 13 12
Pre-existing antibody to NY-ESO-1 antigen 3 7
No. vaccinations
  Median 8 9.5
  Range 2-27 3-21